BL-B01D1
BL-B01D1-207
Phase 2 small_molecule active
Quick answer
BL-B01D1 for Non-small Cell Lung Cancer is a Phase 2 program (small_molecule) at Sichuan Baili Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sichuan Baili Pharmaceutical Co.,
- Indication
- Non-small Cell Lung Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active